Skip to main content

Table 3 Clinical data of 5 cases diagnosed with Malassezia otitis with and without neutrophils

From: Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: A case series

 

Breed

Age (years)

Sex

Type of otitis

Duration of otitis

Previous treatments

Therapy at presentation

Case 1

Labrador Retriever

3.1

FS

Bilateral

SMO

3 months

Topical Aurizon®

Topical Osurnia®

Topical acetylcysteine

Topical magistral solution containing enrofloxacin

Prednisolone 0.5mg/kg q48h for 5 weeks

No topicals treatments for one week

Case 2

Rottweiler

4.3

M

Unilateral SMO

1 year

Ear flush

Prednisolone 0.25 mg/kg q48h for 6 months

Ketoconazole 10 mg/kg q24h for 6 weeks

Case 3

Labrador Retriever

10.5

FS

Bilateral

SMO

5 years

Osurnia® and SurosolveTM

None for 4 weeks

Case 4

Cross Breed

2.9

M

Bilateral: MO on the left ear and SMO on the right ear

2 years

Surolan®

Easotic®

Ear flush

Meloxicam oral

No topical treatments for two weeks

Case 5

Labrador Retriever

4.9

M

Unilateral: MO

14 months

Marbodex®

Marbofloxacin PO

Surolan®

Ketoconazole 12 mg/kg PO q48h for several months

No topical treatments for several months

  1. Ingredients of medication: Aurizon® (Clotrimazole, Dexamethasone, Marbofloxacin), Acetylcysteine (Lysomucil 10%; Zambon S.A., Brussels, Belgium), SurosolveTM (tromethamine-ethylenediaminetetraacetic acid (Tris-EDTA), chloroxylenol, salicylic acid); Marbodex® (marbofloxacin, clotrimazole, dexamethasone), Osurnia® (florfenicol, terbinafine and betamethasone.); Easotic® (hydrocortisone aceponate, miconazole and gentamicin); polymyxin, prednisolone and miconazole (Surolan®; Janssen Pharmaceutica NV, Beerse, Belgium)
  2. Abbreviations: FS Female Spayed, MO Malassezia otitis, M Male, PO Per os SMO Suppurative Malassezia Otitis